SOPHiA GENETICS SA
SOPH
$3.12
-$0.18-5.46%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 65.17M | 64.49M | 64.94M | 64.18M | 62.37M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 65.17M | 64.49M | 64.94M | 64.18M | 62.37M |
Cost of Revenue | 21.24M | 20.75M | 20.59M | 20.56M | 19.46M |
Gross Profit | 43.94M | 43.73M | 44.35M | 43.62M | 42.91M |
SG&A Expenses | 76.32M | 77.04M | 78.43M | 81.83M | 81.72M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -183.00K | -244.00K | -947.00K | -970.00K | -983.00K |
Total Operating Expenses | 131.74M | 132.53M | 134.16M | 138.45M | 137.17M |
Operating Income | -66.57M | -68.04M | -69.22M | -74.27M | -74.80M |
Income Before Tax | -61.27M | -70.78M | -66.00M | -72.29M | -78.49M |
Income Tax Expenses | 1.22M | 615.00K | 784.00K | 696.00K | 487.00K |
Earnings from Continuing Operations | -62.49 | -71.40 | -66.78 | -72.99 | -78.98 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -62.49M | -71.40M | -66.78M | -72.99M | -78.98M |
EBIT | -66.57M | -68.04M | -69.22M | -74.27M | -74.80M |
EBITDA | -62.24M | -63.73M | -64.53M | -69.05M | -69.46M |
EPS Basic | -0.95 | -1.09 | -1.02 | -1.12 | -1.22 |
Normalized Basic EPS | -0.58 | -0.67 | -0.63 | -0.70 | -0.76 |
EPS Diluted | -0.95 | -1.09 | -1.02 | -1.12 | -1.22 |
Normalized Diluted EPS | -0.58 | -0.67 | -0.63 | -0.70 | -0.76 |
Average Basic Shares Outstanding | 263.51M | 262.64M | 261.32M | 259.91M | 258.84M |
Average Diluted Shares Outstanding | 263.51M | 262.64M | 261.32M | 259.91M | 258.84M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |